My bookmarksSign up free
Source

Commission Regulation (EU) 2018/675 of 2 May 2018 amending the Appendices to Annex XVII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) as regards CMR substances (Text with EEA relevance. )

Commission Regulation (EU) 2018/675 of 2 May 2018 amending the Appendices to Annex XVII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) as regards CMR substances (Text with EEA relevance. )

Regulation (EU) 2018/675 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

Annex XVII to Regulation (EC) No 1907/2006 is amended in accordance with the Annex.

Article 2

Open ↗

1.   This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union. 2.   It shall apply from 1 December 2018 except that, to the extent that paragraph 2 of the Annex applies to the substance ‘formaldehyde … %’, that paragraph shall apply from the date of entry into force.

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX Annex XVII to Regulation (EC) No 1907/2006 is amended as follows: (1) Column 1 of entries 28 to 30 is replaced by the following: ‘28. Substances which are classified as carcinogen category 1A or 1B in Part 3 of Annex VI to Regulation (EC) No 1272/2008 and are listed in Appendix 1 or Appendix 2, respectively. 29. Substances which are classified as germ cell mutagen category 1A or 1B in Part 3 of Annex VI to Regulation (EC) No 1272/2008 and are listed in Appendix 3 or Appendix 4, respectively. 30. Substances which are classified as reproductive toxicant category 1A or 1B in Part 3 of Annex VI to Regulation (EC) No 1272/2008 and are listed in Appendix 5 or Appendix 6, respectively.’ (2) In Appendix 2, the following entries are inserted in the table in order of the index numbers set out therein: ‘2,3-epoxypropyl methacrylate; glycidyl methacrylate 607-123-00-4 203-441-9 106-91-2   cadmium carbonate 048-012-00-5 208-168-9 513-78-0   cadmium hydroxide; cadmium dihydroxide 048-013-00-0 244-168-5 21041-95-2   cadmium nitrate; cadmium dinitrate 048-014-00-6 233-710-6 10325-94-7   formaldehyde … % 605-001-00-5 200-001-8 50-00-0   anthraquinone 606-151-00-4 201-549-0 84-65-1   N,N′-methylenedimorpholine; N,N′-methylenebismorpholine; [formaldehyde released from N,N′-methylenebismorpholine]; [MBM] 607-721-00-5 227-062-3 5625-90-1   reaction products of paraformaldehyde and 2-hydroxypropylamine (ratio 3:2); [formaldehyde released from 3,3′-methylenebis[5-methyloxazolidine]; formaldehyde released from oxazolidin]; [MBO] 612-290-00-1 — —   reaction products of paraformaldehyde with 2-hydroxypropylamine (ratio 1:1); [formaldehyde released from α,α,α-trimethyl-1,3,5-triazine-1,3,5(2H,4H,6H)-triethanol]; [HPT] 612-291-00-7 — —   methylhydrazine 612-292-00-2 200-471-4 60-34-4’   (3) In Appendix 4, the following entries are inserted in the table in order of the index numbers set out therein: ‘cadmium carbonate 048-012-00-5 208-168-9 513-78-0   cadmium hydroxide; cadmium dihydroxide 048-013-00-0 244-168-5 21041-95-2   cadmium nitrate; cadmium dinitrate 048-014-00-6 233-710-6 10325-94-7’   (4) In Appendix 6, the following entries are inserted in the table in order of the index numbers set out therein: ‘2-methyl-1-(4-methylthiophenyl)-2-morpholinopropan-1-one 606-041-00-6 400-600-6 71868-10-5   2,3-epoxypropyl methacrylate; glycidyl methacrylate 607-123-00-4 203-441-9 106-91-2   cyproconazole (ISO); (2RS,3RS;2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol 650-032-00-X — 94361-06-5   dibutyltin dilaurate; dibutyl[bis(dodecanoyloxy)]stannane 050-030-00-3 201-039-8 77-58-7   nonadecafluorodecanoic acid; [1] ammonium nonadecafluorodecanoate; [2] sodium nonadecafluorodecanoate [3] 607-720-00-X 206-400-3 [1] 221-470-5 [2] [3] 335-76-2 [1] 3108-42-7 [2] 3830-45-3 [3]   triadimenol (ISO); (1RS,2RS;1RS,2SR)-1-(4-chlorophenoxy)-3,3-dimethyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol; α-tert-butyl-β-(4-chlorophenoxy)-1H-1,2,4-triazole-1-ethanol 613-322-00-7 259-537-6 55219-65-3   quinolin-8-ol; 8-hydroxyquinoline 613-324-00-8 205-711-1 148-24-3   thiacloprid (ISO); (Z)-3-(6-chloro-3-pyridylmethyl)-1,3-thiazolidin-2-ylidenecyanamide; {(2Z)-3-[(6-chloropyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene}cyanamide 613-325-00-3 — 111988-49-9   carbetamide (ISO); (R)-1-(ethylcarbamoyl)ethyl carbanilate; (2R)-1-(ethylamino)-1-oxopropan-2-yl phenylcarbamate 616-223-00-7 240-286-6 16118-49-3’

Other acts of the same type
Commission Delegated Regulation (EU) 2019/979 of 14 March 2019 supplementing Regulation (EU) 2017/1129 of the European Parliament and of the Council with regard to regulatory technical standards on key financial information in the summary of a prospectus, the publication and classification of prospectuses, advertisements for securities, supplements to a prospectus, and the notification portal, and repealing Commission Delegated Regulation (EU) No 382/2014 and Commission Delegated Regulation (EU) 2016/301 (Text with EEA relevance)Commission Delegated Regulation (EU) 2019/980 of 14 March 2019 supplementing Regulation (EU) 2017/1129 of the European Parliament and of the Council as regards the format, content, scrutiny and approval of the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Commission Regulation (EC) No 809/2004 (Text with EEA relevance)Commission Delegated Regulation (EU) 2019/1000 of 14 March 2019 amending Delegated Regulation (EU) 2017/1799 as regards the exemption of the People's Bank of China from the pre- and post-trade transparency requirements in Regulation (EU) No 600/2014 of the European Parliament and of the Council (Text with EEA relevance.)Commission Delegated Regulation (EU) 2019/1143 of 14 March 2019 amending Delegated Regulation (EU) 2015/2446 as regards the declaration of certain low-value consignmentsCommission Delegated Regulation (EU) 2019/1188 of 14 March 2019 supplementing Regulation (EU) No 305/2011 of the European Parliament and of the Council by establishing classes of performance in relation to resistance to wind load for external blinds and awnings (Text with EEA relevance.)Commission Delegated Regulation (EU) 2019/1342 of 14 March 2019 supplementing Regulation (EU) No 305/2011 of the European Parliament and of the Council by establishing classes of performance in relation to air permeability for rooflights of plastics and glass and roof hatches (Text with EEA relevance.)Commission Delegated Regulation (EU) 2020/1423 of 14 March 2019 on supplementing Directive (EU) 2015/2366 of the European Parliament and of the Council with regard to regulatory technical standards on the criteria for appointing central contact points within the field of payment services and on the functions of those central contact points (Text with EEA relevance)Commission Implementing Regulation (EU) 2019/403 of 13 March 2019 granting a Union authorisation for the biocidal product family ‘Deosan Activate BPF based on Iodine’Commission Implementing Regulation (EU) 2019/423 of 13 March 2019 granting a Union authorisation for the biocidal product family ‘Teat disinfectants biocidal product family of Novadan’Commission Delegated Regulation (EU) 2019/807 of 13 March 2019 supplementing Directive (EU) 2018/2001 of the European Parliament and of the Council as regards the determination of high indirect land-use change-risk feedstock for which a significant expansion of the production area into land with high carbon stock is observed and the certification of low indirect land-use change-risk biofuels, bioliquids and biomass fuelsCommission Delegated Regulation (EU) 2019/827 of 13 March 2019 on criteria to be fulfilled by the professional operators in order to comply with the conditions set out in Article 89(1) point (a) of Regulation (EU) 2016/2031 of the European Parliament and of the Council and procedures to ensure that those criteria are metCommission Delegated Regulation (EU) 2019/887 of 13 March 2019 on the model financial regulation for public-private partnership bodies referred to in Article 71 of Regulation (EU, Euratom) 2018/1046 of the European Parliament and of the Council

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next